The ITPKC gene helps put a brake on immune signals inside certain white blood cells, which helps keep inflammation under control. In medicine, this gene is important because it helps regulate calcium based signaling that switches immune cells on. If the gene works less well, immune responses may become harder to control. Some variants in the ITPKC gene are linked to a higher chance of Kawasaki disease and to changes in the arteries around the heart in affected children.
What is a gene?
Genes are stretches of DNA that give cells instructions for making molecules or directing processes throughout the body. Some genes carry the code for proteins, which are the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they happen, and how active they are. In combination, genes affect body development and function, and they can also influence your response to food, stress, and medicines. More detail is available in the LearnHub.
Overview
ITPKCGene function
What if the gene works
The ITPKC gene helps control immune signals inside cells by adjusting calcium signals. This helps put a brake on immune cells called T cells and keeps inflammation more balanced.
Risk
What if the gene does not work
Milder or more severe variants in the ITPKC gene can reduce control of immune signaling, which may increase Kawasaki disease risk and, in some children, lead to more intense inflammation or coronary artery changes.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently tailored to pathogenic variants in the ITPKC gene in clinical guidelines. The ITPKC gene is being studied as a biomarker in Kawasaki disease because some variants may be linked to stronger inflammation or a different response to intravenous immunoglobulin, but this has not changed standard care.
Gene function
What if the gene works
Immune cells need clear internal signals to know when to respond and when to settle down. The ITPKC gene helps regulate calcium signaling in immune cells during normal immune responses. Understanding ITPKC gene function can make it easier to see how the body keeps immune activity measured and organized.
The ITPKC gene changes IP3, a small messenger inside cells, into IP4. This helps cells pass signals forward in a controlled way during everyday communication.
By adjusting IP3 levels, the ITPKC gene helps control how much calcium is released inside the cell. Calcium acts as a short internal signal that tells immune cells when to become active.
In T cells, this gene helps keep activation signals from becoming too strong or lasting too long. That steady pacing supports a more balanced immune response during routine immune triggers.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These changes are common and form part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the ITPKC gene change how much working enzyme a cell makes or how well that enzyme performs. This is the main way ITPKC gene variants affect protein function, with milder variants often causing a partial drop in activity, while more disruptive variants can greatly reduce protein stability or enzyme activity. As a result, cells may have less controlled calcium signaling, especially in immune cells, and the functional impact can vary from subtle to more marked.
How variants are linked to conditions
Variants in the ITPKC gene are most often linked to Kawasaki disease, a childhood illness that causes inflammation in blood vessels. In studies of ITPKC gene variants and Kawasaki disease risk, some changes have also been associated with a higher chance of coronary artery complications and a lower response to standard IVIG treatment. These findings describe risk trends, so carrying a variant does not mean a child will definitely develop Kawasaki disease.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely present in the general population. Most do not directly affect health and simply contribute to natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
Changes in the ITPKC gene may slightly affect the chance of developing Kawasaki disease and, in some children, the risk of more severe inflammation or heart artery changes. This gene is only one part of the picture, and age, sex, ancestry, and other immune-related genes can also influence risk.
Inheritance of ITPKC variants
There is not yet a broadly confirmed Mendelian pattern for the inheritance of the ITPKC gene variants in relation to a specific single-gene condition. Instead, changes in the ITPKC gene are mainly studied as risk-influencing factors that may be passed down in families along with many other genetic and non-genetic influences. For families asking about the inheritance of the ITPKC gene variants, this means the gene is inherited in the usual way rather than following a well-established dominant or recessive pattern. The ITPKC gene is located on chromosome 19, which is an autosome, so you inherit one copy from each parent.
What does my ITPKC result mean for my family?
There is not yet a broadly confirmed inherited pattern for ITPKC tied to one specific genetic condition. Changes in this gene are mainly studied as factors that may slightly affect the chance of certain immune-related illnesses, rather than as a result that clearly predicts the same condition in close relatives.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the ITPKC gene, doctors use genetic testing for ITPKC variants on blood, saliva, or a cheek swab. A lab reads the DNA sequence and compares it with the usual pattern to look for variants, which may be benign or may help explain a person's condition.
When should I consider getting a genetic test?
There isn’t yet a broadly established, ITPKC-specific clinical reason for testing in routine care. Decisions about genetic testing are best made with a doctor or genetic counselor, based on your symptoms, diagnosis, and family history.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains varies based on the condition and the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone else. Small differences in genes can influence how the body breaks down a drug, moves it through the body, or responds to it at its target, and these differences are a common part of normal human variation.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medications. It studies patterns between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body processes it. This information can support more informed, more individualized treatment decisions. To explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the ITPKC gene
When should I seek medical advice?
There is not yet a widely confirmed role for this gene in guiding medicine choice or dose, so general questions about symptoms, treatment, or side effects are best discussed with your doctor. Some studies have looked at ITPKC in Kawasaki disease to see whether it relates to response to immune treatment, but this is not part of routine medication decisions.
History
Interest in the ITPKC gene grew when researchers studying Kawasaki disease looked for inherited factors that might help explain why some children develop more intense inflammation than others. A key turning point came in 2008, when a genetic study linked variants in the ITPKC gene to Kawasaki disease risk and to the chance of developing coronary artery changes. From these first observations, research expanded steadily, with follow-up studies in several populations examining how consistent that link was. Over time, descriptions became more precise as scientists compared results across children of different backgrounds. This work helped move Kawasaki disease research beyond symptoms alone and into the genetics of immune response.